4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-016403
Chief Business Officer sold 5,000 shares at $16.01 ($80,050)
From the SEC's structured data for this filing
Trades in this filing
Martin Michael Robert · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-09 | Sale : show line 1 in the form | −5,000 | $16.01 | $80,050 | 206,861 | D |
| Open-market sales · 5,000 sh · avg $16.01 · $80,050 | ||||||
Loading xslF345X03/wf-form4_162862613567685.xml…